MedPath

Post-Traumatic Stress Symptoms (PTSS) in Transplant Recipients

Completed
Conditions
Solid Organ Transplant Recipients
Parent(s)/Guardian of Referenced Transplant Recipients
Registration Number
NCT02892266
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Brief Summary

This study is conducted to better understand Post-Traumatic Stress Symptoms (PTSS) in adolescent transplant recipients and their parent/guardian and to see if PTSS play a role in the way adolescent transplant recipients take their prescribed medicine.

Target population: medically stable adolescent solid organ (e.g., heart, kidney, liver, lung, small bowel) transplant recipients and their parent(s)/guardian.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
124
Inclusion Criteria

The patient:

  • and/or their parent(s)/guardian must be able to understand and provide informed consent in English or Spanish;
  • is prescribed tacrolimus (either brand or generic formulation); and
  • has been seen in the enrolling center's clinic at least twice in the last two years.
Exclusion Criteria

The patient:

  • received a transplant less than 18 months prior to enrollment;
  • has had more than one transplant (including marrow replacement);
  • or their parent(s)/guardian is actively psychotic or severely disoriented due to any cause, including hepatic encephalopathy (temporary exclusion);
  • or their parent(s)/guardian has been diagnosed with severe intellectual disability as defined in the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5);
  • is not medically stable or is hospitalized;
  • is currently enrolled in a study that aims to improve adherence to medical recommendations;
  • is receiving cognitive behavioral therapy for confirmed or suspected diagnosis of Post-Traumatic Stress Disorder (PTSD) at enrollment;
  • is receiving psychotropic medications for a confirmed or suspected diagnosis of PTSD.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Medication Level Variability Index (MLVI)6 months retrospective data to 6 months post enrollment

Defined by fluctuation in medication blood levels. Calculated as the standard deviation (variation) of a minimum of 3 outpatient tacrolimus trough levels, obtained for one year, consisting of 6 months prior to study enrollment plus 6 months post study enrollment.

University of California at Los Angeles Post-Traumatic Stress Disorder Reaction Index DSM-5 (UCLA PTSD RI DSM-5) Total ScoreAt enrollment visit

The UCLA PTSD RI DSM-5 is a widely used and validated self-report questionnaire assessing posttraumatic stress symptoms (PTSS) in children and adolescents ages 8-18 years.

Secondary Outcome Measures
NameTimeMethod
Child Depression/Distress AssessmentAt enrollment visit

Depression/distress measured using the Children's Depression Inventory - Short Form (CDI-S) self-report questionnaire.

Above-threshold Medication Level Variability Index (MLVI)6 months post enrollment

Defined by an MLVI greater than 2.

Diagnosis of chronic allograft rejection6 months retrospective data to 6 months post enrollment
QOL Assessment Using PedsQL Subscale ScoresAt enrollment visit

Measured using the child self-report PedsQL version 4.0 subscale scores.

Above-threshold Child PTSS ScoreAt enrollment visit

Defined as the existence of threshold scores in a symptoms constellation corresponding to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) definition of Post-Traumatic Stress Disorder (PTSD). Method: University of California at Los Angeles Post-Traumatic Stress Disorder Reaction Index DSM-5 version (UCLA PTSD RI DSM-5) self-report questionnaire.

Child Avoidance ScoreAt enrollment visit

Measured by the UCLA Post-Traumatic Stress Disorder Reaction Index (PTSD-RI) self-report subscale summary score.

Diagnosis of graft failure6 months retrospective data to 6 months post enrollment
Parent PTSS Total ScoreAt enrollment visit

Measured using the Impact of Event Scale (IES) self-report questionnaire.

QOL Assessment Using the HRQOL (PedsQL) Total ScoreAt enrollment visit

Measured using the child self-report Transplant-Specific Health-Related Quality of Life (HRQOL) scale (PedsQL) version 4.0 summary score.

Parent AvoidanceAt enrollment visit

Measured using IES self-report questionnaire subscore.

Quality of Life (QOL) Assessment Using the PedsQL Total ScoreAt enrollment visit

Measured using the child self-report Pediatric Quality of Life (PedsQL) version 4.0.

PedsQL Family Impact Total ScoreAt enrollment visit

Measured using the parent/guardian self-report PedsQL Family Impact version 2.0 summary score.

PedsQL Family Impact Subscale ScoresAt enrollment visit

Measured using the parent/guardian self-report PedsQL Family Impact version 2.0 subscale scores.

Types of traumas identified as salient by the parentAt enrollment visit

Measured using the parent/guardian Impact of Event Scale (IES).

Types of traumas identified as salient by the childAt enrollment visit

Measured using the University of California at Los Angeles Post-Traumatic Stress Disorder Reaction Index DSM-5 version (UCLA PTSD RI DSM-5).

Trial Locations

Locations (13)

Ronald Reagan UCLA Medical Center: Pediatric Transplantation

🇺🇸

Los Angeles, California, United States

Lucile Salter Packard Children's Hospital at Stanford: Pediatric Transplantation

🇺🇸

Palo Alto, California, United States

UCSF Benioff Children's Hospital: Pediatric Transplantation

🇺🇸

San Francisco, California, United States

University of Miami, Jackson Memorial Hospital: Pediatric Transplantation

🇺🇸

Miami, Florida, United States

Ann and Robert H. Lurie Children's Hospital of Chicago: Pediatric Transplantation

🇺🇸

Chicago, Illinois, United States

Boston Children's Hospital: Pediatric Transplantation

🇺🇸

Boston, Massachusetts, United States

St. Louis Children's Hospital: Pediatric Transplantation

🇺🇸

Saint Louis, Missouri, United States

Columbia University Medical Center: Pediatric Transplantation

🇺🇸

New York, New York, United States

Cincinnati Children's Hospital Medical Center: Pediatric Transplantation

🇺🇸

Cincinnati, Ohio, United States

Nationwide Children's Hospital

🇺🇸

Columbus, Ohio, United States

Scroll for more (3 remaining)
Ronald Reagan UCLA Medical Center: Pediatric Transplantation
🇺🇸Los Angeles, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.